City

Amsterdam (1)

Beijing (1)

Caen (1)

Condition

Resectable Carcinoma (3)

Esophageal Adenocarcinoma (1)

Gastric Cancer by AJCC V8 Stage (1)

Oesophageal Adenocarcinoma (1)

Pancreatic Cancer (1)

Overall Status

Recruiting (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (2)

n/a (1)

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)

Centre Francois Baclesse (1)

Peking Union Medical College Hospital (1)

Collaborator

National Cancer Institute, France (1)

Noordwest Ziekenhuisgroep (1)

Intervention

carboplatin (1)

external beam radiotherapy (1)

later-line therapy (1)

paclitaxel (1)

perioperative treatment (1)

tocilizumab 20 mg/ml intravenous solution (1)

Study Documents

Intervention Type

drug (3)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

resectable carcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Pancreatic Cancer, Resectable Carcinoma Trial in Beijing (Later-line therapy)

Recruiting

Pancreatic Cancer
Resectable Carcinoma

Later-line therapy

Beijing, China

Department of Medical Oncology, Peking Union Medical College Hos

Apr 10, 2023

Esophageal Adenocarcinoma, Oesophageal Adenocarcinoma, Resectable Carcinoma Trial in Amsterdam (Tocilizumab 20 Mg/mL Intravenous

Active, not recruiting

Esophageal Adenocarcinoma
+2 more

Tocilizumab 20 Mg/mL Intravenous Solution
+3 more

Amsterdam, Netherlands

Academic Medical Center, Medical Oncology

Dec 15, 2022

Gastric Cancer by AJCC V8 Stage, Resectable Carcinoma Trial in Caen (perioperative treatment)

Recruiting

Gastric Cancer by AJCC V8 Stage
Resectable Carcinoma

perioperative treatment

Caen, France

Centre François Baclesse

Jun 28, 2021